Adipocytokine profile in children with Kawasaki disease at a mean follow-up period of 5.5 years: A study from North India

Table 1 Clinical and laboratory features of the study population

	Study group (n = 20)	Controls (n = 20)
Male:female ratio	1.5:1	1.5:1
Age at diagnosis < 5 yr	9	-
Age at diagnosis >5 yr	11	-
Mean age at enrolment (yr)	10.1	9.1
Mean duration of follow-up (yr)	5.5	-
Treatment received during the acute phase		-
IVIg (mg/dL)	20
Aspirin (mg/dL)	20
CAAs (mg/dL)	4/20	-
Lipid profile	mean ± SD	-
LDL (mg/dL)	74.73 ± 27.82
TG (mg/dL)	118.72 ± 104.32
VLDL (mg/dL)	16.96 ± 6.72
HDL (mg/dL)	44.93 ± 11.40
TC (mg/dL)	139.76 ± 27.16
Body mass index (kg/m2)	16.68 ± 3.25	-
Lipid profile (18/20)		-
High TC (mg/dL)	2
High LDL (mg/dL)	2
Low HDL (mg/dL)	6
Borderline HDL (mg/dL)	11
High TG (mg/dL)	4
High VLDL (mg/dL)	0

IVIg: Intravenous immunoglobulin; KD: Kawasaki disease; TC: Total cholesterol; LDL: Low density lipoprotein; HDL: High density lipoprotein; VLDL: Very low density lipoprotein; TG: Triglycerides, CAAs: Coronary artery abnormalities; SD: Standard deviation.